Prostate cancer: New drug for aggressive, resistant cases
Enzalutamide reduced metastasis or death risk by 71 percent in phase III trial of castration-resistant nonmetastatic prostate cancer with escalating PSA.
Prostate cancer: Scientists find 63 'new genetic markers'
Research locates new genetic markers that may show an elevated risk of developing prostate cancer. This will help to identify men who need early screening.
Immunotherapy effective against 'untreatable' prostate cancer
For the first time, a major clinical trial shows that immunotherapy can successfully treat very advanced forms of prostate cancer.
Targeting this gene could kill prostate cancer
Could a long noncoding RNA that has a role in androgen receptor signaling in prostate cancer be a treatment target that does not lead to resistance?
Can women get prostate cancer?
Women do not have a prostate in the same way as men. They do, however, have Skene glands, often called the female prostate, which have many similarities to the prostate. Cancer of the female prostate is extremely rare. Find out about the functions of the Skene glands and learn more about female prostate cancer here.
Experimental drug targets prostate cancer's chief weakness
In prostate cancer, recurring tumors become aggressive and treatment-resistant. Why does this happen, and how can it be prevented? A new study weighs in.
Prostate cancer: Big data unlocks 80 new drug targets
In the largest study of its type, researchers find several new prostate cancer drug targets by harvesting and analyzing reams of genetic data.
What is the prostate gland?
The prostate gland produces some of the ingredients in semen. Around one third of the fluid in semen comes from the prostate gland. The gland surrounds the urethra. Common problems include an enlarged prostate, prostatitis, and prostate cancer. Treatment is available for all these conditions. Find out more.
'Natural insecticide' kills advanced prostate cancer cells
Scientists identify a class of drugs that selectively targets and kills advanced prostate cancer cells that lack the tumor-suppressor protein PTEN.
Prostate cancer: How a full stomach could improve treatment
A new study finds that the prostate cancer drug Zytiga is more effective, as well as cheaper, when taken with food, as opposed to on an empty stomach.